For clinicians used to watching kidney disease march forward despite treatment, these results were a massive shift
Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats
The LIFE trial (N=9,193) demonstrated losartan's clinical value in a head-to-head comparison against atenolol, showing a 13% reduction in the composite primary endpoint of cardiovascular death, stroke, and myocardial infarction over a mean follow-up of 4.8 years
It was just good experience in the end. -User, Google Review A Great Experience Everything from sign up to intake to my appointment was seamless
A role in tumor development in patients with T2DM is also being investigated but further studies are required to fully understand the functions of GLP-1R and its agonists
I had an amazing experience with this clinic